ACE2 and COVID-19: Thus, there is now an increasing number of studies using mouse genetics involving ACE2 deletion and overexpression, for further understanding of ACE2 biology and for the investigation of ACE2 not only in the pathogenesis and treatment of COVID‐19 but also in human AA nutrition (Jia et al., 2020; Johansen et al., 2020).